317.28 USD
4.18 (1.34%)
Yesterday High
$320.23
Yesterday Low
$309.25
52w High
$354.31
52w Low
$171.37
Market Cap.
$6.9B
52w Change
52.31%
This is a preview of the full version of Prosperse
Trending News
Madrigal Pharmaceuticals, a mid-cap biotech company, has gained FDA approval for its NASH therapy Rezdiffra, making it a potential leader in the field. However, the company faces challenges, including the need to produce positive efficacy data in confirmatory trials and competition from larger pharm...
Prosper Junior Bakiny
Aug 17, 2024
Madrigal Pharmaceuticals, a biopharmaceutical company focused on NASH, announced the appointment of Shannon Kelley as their new General Counsel. Kelley has over 20 years of healthcare experience and previously held roles at Sanofi and Boston Scientific.
N/A
Aug 2, 2024
Login to view more news
Dive into the world of investing with Prosperse
Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.
Read more news from Prosperse
Nvidia and Google Partner to Propel Quantum Computing Processor Development
Date: Nov 19, 2024
Netflix’s Boxing Spectacle Challenges Streaming Capabilities, Pushing Ambitions in Live Sports
Date: Nov 19, 2024
Leading AI Companies Face Diminishing Returns in Model Advancement
Date: Nov 14, 2024
Meta Platforms Inc. Introduces Orion: A Glimpse into the Future of Augmented Reality
Date: Nov 14, 2024
Meta Platforms Inc.'s Stock Rises Despite Challenges Following Trump's Re-election
Date: Nov 14, 2024